Inactive Instrument

Analyst Reco. Coloplast A/S Other OTC

Equities

COLOPLAST : Q1 24: Many more positives beyond the margin beat	02-14
COLOPLAST : EPS cut (2023: -12.9%, 2024: -14.7%)	01-04
COLOPLAST : Q4 23: more misses than hits	12-06
Chinese headwinds could be more severe than expected	23-09-22
Analyst recommendations: Hewlett Packard, Apple, Tesla, Mosaic, Rite Aid...	23-08-30
COLOPLAST : Q3 23: inflation still bites; FY23 margin miss likely	23-08-23
COLOPLAST : Q2 23: Inflation and supply chain headwinds continue to bite	23-05-11
Roadshow - Berenberg	23-02-09	FA
COLOPLAST : Q1 23: largely in line underlying trends even as interest costs bite	23-02-08
COLOPLAST : Q4 22: China weighs on performance; FY23 guidance fails to impress	22-11-16
COLOPLAST : Good Q3; China remains a near-term catalyst	22-08-24
COLOPLAST : Q1 22: guidance cut spooks investors	22-05-06
BNP Paribas Exane MedTech CEO Conference	22-03-28	FA
COLOPLAST : Good start to FY 22	22-01-27
Berenberg European Conference	21-12-05	FA
COLOPLAST : FY 22 guidance plays spoilsport	21-11-02
COLOPLAST : Positive strategic update offsets soft Q3 21 showing	21-08-19
ANALYST RECOMMENDATIONS : Accenture, Comcast, DoorDash, Intel, Roku...	21-06-25
Exane BNP Paribas European CEO Conference	21-06-09	FA
Berenberg US Conference	21-05-17	FA

No results for this search

COLOPLAST : Q1 24: Many more positives beyond the margin beat

February 14, 2024 at 11:08 am